Cargando…
Management of metabolic-associated fatty liver disease: The diabetology perspective
The metabolic syndrome as a consequence of the obesity pandemic resulted in a substantial increase in the prevalence of metabolic-associated fatty live disease (MAFLD) and type 2 diabetes mellitus (T2DM). Because of the similarity in pathobiology shared between T2DM and MAFLD, both disorders coexist...
Autores principales: | Jeeyavudeen, Mohammad Sadiq, Khan, Shahanas K A, Fouda, Sherouk, Pappachan, Joseph M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850951/ https://www.ncbi.nlm.nih.gov/pubmed/36683717 http://dx.doi.org/10.3748/wjg.v29.i1.126 |
Ejemplares similares
-
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023) -
Individualized diabetes care: Lessons from the real-world experience
por: Khor, Xiao Ying, et al.
Publicado: (2023) -
Diabetes and cognitive function: An evidence-based current perspective
por: Sebastian, Meghna Julian, et al.
Publicado: (2023) -
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
por: Fouda, Sherouk, et al.
Publicado: (2022) -
Management of diabesity: Current concepts
por: Michaelidou, Maria, et al.
Publicado: (2023)